In an article published in Law360, Hollingsworth LLP spotlights the ban on BPA in a growing number of states.
A Texas federal judge . . . ruled against a cancer patient who sued Novartis Pharmaceuticals Corp. over a jaw injury she allegedly sustained after taking Zometa, handing Novartis the latest of several wins in multidistrict litigation over the bone drug in the past several months.
Law360: Novartis Ruling Helps New Jersey Drug Companies Fend Off Punitive Damages
news | September 7, 2012A Maryland federal judge ruled Wednesday that a woman cannot pursue punitive damages under New Jersey law for an injury allegedly caused by Novartis Pharmaceuticals Corp. bone drugs because they are preempted by federal law, a decision that makes it more difficult for plaintiffs in product liability actions to seek such damages from New Jersey-based drugmakers, experts say.
Hudson Valley Federal Credit Union v. New York Department of Taxation and Finance
news | May 17, 2012Firm files amicus brief on behalf of American and New York Bankers Associations' position that federal credit unions are not exempt or immune from paying mortgage recording tax.
Washington, DC, June 2012 — Hollingsworth LLP once again sponsors Lawyers Have Heart 10K
news | May 7, 2012For more than fifteen years, Hollingsworth LLP has been a major sponsor of the annual Lawyers Have Heart 10K Run, which, since its creation, has raised more than $7.5 million to benefit the American Heart Association. …
Hollingsworth LLP named for the second time in three years to the National Law Journal‘s Midsize Firm Hot List.
news | April 20, 2012On April 20, 2012, the National Law Journal named Hollingsworth LLP for the second time to its Midsize Hot List, an annual list that recognizes twenty midsize firms around the country. Click here to read the…
DRI's The Voice
St. Louis Federal Jury Returns Verdict for Novartis in Second Zometa Defense Verdict in a Week
news | February 1, 2012On two consecutive days, two different federal juries returned defense verdicts in favor of Firm client Novartis Pharmaceuticals Corporation in trials arising out of the federal MDL litigation pending in the Middle District of Tennessee, In re…
Four Firm partners credited for summary judgment decision in N.D. Ga. products liability case.
news | January 11, 2012DRI's The Voice
Final Philadelphia Gadolinium-Based Contrast Agent Personal Injury Case Dismissed
news | January 3, 2012In early 2010, Hollingsworth LLP began defending 32 Gadolinium-Based Contrast Agent (GBCA) personal injury cases pending in the Philadelphia Court of Common Pleas Complex Litigation Center on behalf of Firm clients General Electric Company and GE…
Hollingsworth LLP Files Industry Coalition Amicus Brief in U.S. Supreme Court
news | October 13, 2011This industry coalition brief was filed on behalf of the U.S. Chamber of Commerce, American Chemistry Council, American Coatings Association, American Insurance Association, American Petroleum Institute, and National Association of Manufacturers.